185 related articles for article (PubMed ID: 33558888)
1. Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway.
Tong F; Shen W; Song P; Song J; Hu Y; Liu F; Meng Z; Liu J
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33558888
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4/NOX4/NF-κB pathway.
Yao Y; Hu X; Feng X; Zhao Y; Song M; Wang C; Fan H
J Cell Biochem; 2019 Oct; 120(10):18509-18523. PubMed ID: 31243816
[TBL] [Abstract][Full Text] [Related]
4. [Dexmedetomidine preconditioning alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats by inhibiting NLRP3 inflammasome activation].
Han B; Chen M; Yang C; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1857-1863. PubMed ID: 35012919
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study on the inhibition of the NLRP3 signaling pathway with Shengsan Jiedu Huayu decoction to alleviate inflammatory injury in rats with acute-on-chronic liver failure].
Liu X; Meng JL; Wang MG; Mao DW; Dai M
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):354-362. PubMed ID: 38733191
[No Abstract] [Full Text] [Related]
6. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine alleviates blunt chest trauma and hemorrhagic shock‑resuscitation‑induced acute lung injury through inhibiting the NLRP3 inflammasome.
Ming T; Yuan M; Kong Q; Huang Q; Xia Z; Wu X
Mol Med Rep; 2020 Sep; 22(3):2507-2515. PubMed ID: 32705267
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene Protects Against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Upregulating the Nrf2 Pathway and Inhibiting NF-
Zhang E; Huang J; Wang K; Yu Q; Zhu C; Ren H
J Med Food; 2020 Sep; 23(9):952-960. PubMed ID: 32701014
[TBL] [Abstract][Full Text] [Related]
11. Atractylodin ameliorates lipopolysaccharide and d-galactosamine-induced acute liver failure via the suppression of inflammation and oxidative stress.
Lyu Z; Ji X; Chen G; An B
Int Immunopharmacol; 2019 Jul; 72():348-357. PubMed ID: 31030090
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
[TBL] [Abstract][Full Text] [Related]
13. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine Alleviates Hyperoxia-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation.
Zhang Q; Wu D; Yang Y; Liu T; Liu H
Cell Physiol Biochem; 2017; 42(5):1907-1919. PubMed ID: 28873369
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine attenuates ventilator-induced lung injury in rats by up-regulating NLRC3.
Zhang B; Zhang X; Li Q; Ma F; Sun L; Wang M
Ann Palliat Med; 2020 Sep; 9(5):2474-2484. PubMed ID: 32787359
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine alleviates LPS‑induced acute lung injury via regulation of the p38/HO‑1 pathway.
Sun Y; Xia Y; Liu X; Liu J; He W; Ye H; Yuan X
Mol Med Rep; 2020 Sep; 22(3):2442-2450. PubMed ID: 32705282
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR-381.
Zhang Y; Wang X; Liu Z; Yu L
J Biochem Mol Toxicol; 2018 Nov; 32(11):e22211. PubMed ID: 30102002
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
[TBL] [Abstract][Full Text] [Related]
19. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway.
Zhang Z; Tian L; Jiang K
Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression.
Li Y; Pan Y; Gao L; Lu G; Zhang J; Xie X; Tong Z; Li B; Li G; Li W
Biochem Biophys Res Commun; 2018 Jan; 495(4):2439-2447. PubMed ID: 29269298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
